 Fauquier ENT News
Called Neffy, it was approved by the FDA on 8/9/24. Neffy is a single dose nasal spray administered into one nostril. As with epinephrine injection products, a second dose (using the new nasal spray to administer neffy in the same nostril) may be given if there is no improvement in symptoms or symptoms worsen. The cost of neffy is anticipated to be around $199 for two doses via digital pharmacy sites like GoodRx and around $25 for commercially insured patients through a co-pay savings program. Neffy’s approval was based on four studies in 175 healthy adults, without anaphylaxis, that measured the epinephrine concentrations in the blood following administration of neffy or approved epinephrine injection products. Results from these... Read the whole entry... » 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. | 
